Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

A viral kinase counteracts in vivo restriction of murine cytomegalovirus by SAMHD1.

Deutschmann J, Schneider A, Gruska I, Vetter B, Thomas D, Kießling M, Wittmann S, Herrmann A, Schindler M, Milbradt J, Ferreirós N, Winkler TH, Wiebusch L, Gramberg T.

Nat Microbiol. 2019 Dec;4(12):2273-2284. doi: 10.1038/s41564-019-0529-z. Epub 2019 Sep 23.

PMID:
31548683
2.

Human cytomegalovirus overcomes SAMHD1 restriction in macrophages via pUL97.

Businger R, Deutschmann J, Gruska I, Milbradt J, Wiebusch L, Gramberg T, Schindler M.

Nat Microbiol. 2019 Dec;4(12):2260-2272. doi: 10.1038/s41564-019-0557-8. Epub 2019 Sep 23.

PMID:
31548682
3.

IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation.

Hotter D, Bosso M, Jønsson KL, Krapp C, Stürzel CM, Das A, Littwitz-Salomon E, Berkhout B, Russ A, Wittmann S, Gramberg T, Zheng Y, Martins LJ, Planelles V, Jakobsen MR, Hahn BH, Dittmer U, Sauter D, Kirchhoff F.

Cell Host Microbe. 2019 Jun 12;25(6):858-872.e13. doi: 10.1016/j.chom.2019.05.002. Epub 2019 Jun 4.

PMID:
31175045
4.

Correction to: The SAMHD1-mediated block of LINE-1 retroelements is regulated by phosphorylation.

Herrmann A, Wittmann S, Thomas D, Shepard CN, Kim B, Ferreirós N, Gramberg T.

Mob DNA. 2018 May 1;9:16. doi: 10.1186/s13100-018-0121-8. eCollection 2018.

5.

The SAMHD1-mediated block of LINE-1 retroelements is regulated by phosphorylation.

Herrmann A, Wittmann S, Thomas D, Shepard CN, Kim B, Ferreirós N, Gramberg T.

Mob DNA. 2018 Mar 28;9:11. doi: 10.1186/s13100-018-0116-5. eCollection 2018. Erratum in: Mob DNA. 2018 May 1;9:16.

6.

SAMHD1 in Retroviral Restriction and Innate Immune Sensing--Should We Leash the Hound?

Herrmann A, Happel AU, Gramberg T.

Curr HIV Res. 2016;14(3):225-34. Review.

PMID:
26957197
7.

Editorial: Strategies to Defeat HIV.

Serra-Moreno R, Gramberg T.

Curr HIV Res. 2016;14(3):173-4. No abstract available.

PMID:
26957193
8.

TRIM19/PML Restricts HIV Infection in a Cell Type-Dependent Manner.

Kahle T, Volkmann B, Eissmann K, Herrmann A, Schmitt S, Wittmann S, Merkel L, Reuter N, Stamminger T, Gramberg T.

Viruses. 2015 Dec 23;8(1). pii: E2. doi: 10.3390/v8010002.

9.

Phosphorylation of murine SAMHD1 regulates its antiretroviral activity.

Wittmann S, Behrendt R, Eissmann K, Volkmann B, Thomas D, Ebert T, Cribier A, Benkirane M, Hornung V, Bouzas NF, Gramberg T.

Retrovirology. 2015 Dec 15;12:103. doi: 10.1186/s12977-015-0229-6.

10.

Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA.

Herzner AM, Hagmann CA, Goldeck M, Wolter S, Kübler K, Wittmann S, Gramberg T, Andreeva L, Hopfner KP, Mertens C, Zillinger T, Jin T, Xiao TS, Bartok E, Coch C, Ackermann D, Hornung V, Ludwig J, Barchet W, Hartmann G, Schlee M.

Nat Immunol. 2015 Oct;16(10):1025-33. doi: 10.1038/ni.3267. Epub 2015 Sep 7.

11.

Cytoplasmic HIV-RNA in monocytes determines microglial activation and neuronal cell death in HIV-associated neurodegeneration.

Faissner S, Ambrosius B, Schanzmann K, Grewe B, Potthoff A, Münch J, Sure U, Gramberg T, Wittmann S, Brockmeyer N, Uberla K, Gold R, Grunwald T, Chan A.

Exp Neurol. 2014 Nov;261:685-97. doi: 10.1016/j.expneurol.2014.08.011. Epub 2014 Aug 19.

PMID:
25150097
12.

Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response.

Behrendt R, Schumann T, Gerbaulet A, Nguyen LA, Schubert N, Alexopoulou D, Berka U, Lienenklaus S, Peschke K, Gibbert K, Wittmann S, Lindemann D, Weiss S, Dahl A, Naumann R, Dittmer U, Kim B, Mueller W, Gramberg T, Roers A.

Cell Rep. 2013 Aug 29;4(4):689-96. doi: 10.1016/j.celrep.2013.07.037. Epub 2013 Aug 22.

13.

Restriction of diverse retroviruses by SAMHD1.

Gramberg T, Kahle T, Bloch N, Wittmann S, Müllers E, Daddacha W, Hofmann H, Kim B, Lindemann D, Landau NR.

Retrovirology. 2013 Mar 5;10:26. doi: 10.1186/1742-4690-10-26.

14.

SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, Schenkova K, Ambiel I, Wabnitz G, Gramberg T, Panitz S, Flory E, Landau NR, Sertel S, Rutsch F, Lasitschka F, Kim B, König R, Fackler OT, Keppler OT.

Nat Med. 2012 Nov;18(11):1682-7. doi: 10.1038/nm.2964.

15.

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.

Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F.

Nat Immunol. 2012 Feb 12;13(3):223-228. doi: 10.1038/ni.2236. Erratum in: Nat Immunol. 2013 Aug;14(8):877.

16.

Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx.

Gramberg T, Sunseri N, Landau NR.

J Virol. 2010 Feb;84(3):1387-96. doi: 10.1128/JVI.01437-09. Epub 2009 Nov 18.

17.

Accessories to the crime: recent advances in HIV accessory protein biology.

Gramberg T, Sunseri N, Landau NR.

Curr HIV/AIDS Rep. 2009 Feb;6(1):36-42. Review.

18.

Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: Differential pH dependence, internalization and virion binding.

Gramberg T, Soilleux E, Fisch T, Lalor PF, Hofmann H, Wheeldon S, Cotterill A, Wegele A, Winkler T, Adams DH, Pöhlmann S.

Virology. 2008 Mar 30;373(1):189-201. Epub 2008 Feb 20.

19.

A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.

Pöhlmann S, Münch J, Aziz S, Reeves JD, Otto C, Leslie GJ, Hofmann H, Puffer BA, Baribaud F, Marzi A, Gramberg T, Chen Z, Stolte N, Haaft PT, Heeney JL, Stahl-Hennig C, Mätz-Rensing K, Schneider T, Doms RW, Kirchhoff F.

Virology. 2007 Apr 10;360(2):275-85. Epub 2006 Nov 28.

20.

Interaction between the spike protein of human coronavirus NL63 and its cellular receptor ACE2.

Pöhlmann S, Gramberg T, Wegele A, Pyrc K, van der Hoek L, Berkhout B, Hofmann H.

Adv Exp Med Biol. 2006;581:281-4. No abstract available.

PMID:
17037543
21.

Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63.

Hofmann H, Marzi A, Gramberg T, Geier M, Pyrc K, van der Hoek L, Berkhout B, Pöhlmann S.

Adv Exp Med Biol. 2006;581:219-27. Review. No abstract available.

PMID:
17037533
22.

DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets.

Chaipan C, Soilleux EJ, Simpson P, Hofmann H, Gramberg T, Marzi A, Geier M, Stewart EA, Eisemann J, Steinkasserer A, Suzuki-Inoue K, Fuller GL, Pearce AC, Watson SP, Hoxie JA, Baribaud F, Pöhlmann S.

J Virol. 2006 Sep;80(18):8951-60.

23.

Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors.

Hofmann H, Simmons G, Rennekamp AJ, Chaipan C, Gramberg T, Heck E, Geier M, Wegele A, Marzi A, Bates P, Pöhlmann S.

J Virol. 2006 Sep;80(17):8639-52.

24.

The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.

Marzi A, Akhavan A, Simmons G, Gramberg T, Hofmann H, Bates P, Lingappa VR, Pöhlmann S.

J Virol. 2006 Jul;80(13):6305-17.

25.

Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN.

Caminschi I, Corbett AJ, Zahra C, Lahoud M, Lucas KM, Sofi M, Vremec D, Gramberg T, Pöhlmann S, Curtis J, Handman E, van Dommelen SL, Fleming P, Degli-Esposti MA, Shortman K, Wright MD.

Int Immunol. 2006 May;18(5):741-53. Epub 2006 Mar 28.

PMID:
16569675
26.

Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens.

Gramberg T, Zhu T, Chaipan C, Marzi A, Liu H, Wegele A, Andrus T, Hofmann H, Pöhlmann S.

Virology. 2006 Apr 10;347(2):354-63. Epub 2006 Jan 18.

27.

Evidence that multiple defects in murine DC-SIGN inhibit a functional interaction with pathogens.

Gramberg T, Caminschi I, Wegele A, Hofmann H, Pöhlmann S.

Virology. 2006 Feb 20;345(2):482-91. Epub 2005 Nov 17.

28.

LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus.

Gramberg T, Hofmann H, Möller P, Lalor PF, Marzi A, Geier M, Krumbiegel M, Winkler T, Kirchhoff F, Adams DH, Becker S, Münch J, Pöhlmann S.

Virology. 2005 Sep 30;340(2):224-36.

29.

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Marzi A, Gramberg T, Simmons G, Möller P, Rennekamp AJ, Krumbiegel M, Geier M, Eisemann J, Turza N, Saunier B, Steinkasserer A, Becker S, Bates P, Hofmann H, Pöhlmann S.

J Virol. 2004 Nov;78(21):12090-5.

30.

Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.

Hofmann H, Geier M, Marzi A, Krumbiegel M, Peipp M, Fey GH, Gramberg T, Pöhlmann S.

Biochem Biophys Res Commun. 2004 Jul 9;319(4):1216-21.

PMID:
15194496
31.

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.

Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Uberla K, Niedrig M, Pöhlmann S.

J Virol. 2004 Jun;78(12):6134-42.

Supplemental Content

Loading ...
Support Center